Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank

Table 1 Differences in mortality and co-morbidity amongst males and females testing positive for Covid-19

	Male	Female	Odds ratio (95% CI)	P
N	835	747	–	–
Died (n)	200	105	1.93 (1.49–2.51)	< 0.0001
Age (mean years ± SD)	69 ± 9	66 ± 9	–	< 0.0001
BMI (kg/m², mean ± SD	28.9 ± 4.8	28.6 ± 6.1	–	0.32
Hypertension (n)	343	226	1.61 (1.31–1.98)	< 0.0001
Dyslipidaemia (n)	206	97	2.20 (1.68–2.86)	< 0.0001
Atrial fibrillation (n)	109	35	3.05 (2.06–4.58)	< 0.0001
Ventricular arrhythmia (n)	9	1	8.13 (1.36–89.41)	0.02
Diabetes (n)	150	74	1.99 (1.47–2.70)	< 0.0001
Stroke (n)	20	15	1.20 (0.63–2.29)	0.61
Angina (n)	123	54	2.21 (1.58–3.08)	< 0.0001

Male participants testing positive have a higher odds ratio for mortality than their female counterparts. Males testing positive were older and had a greater comorbidity, although there was no difference in BMI or history of stroke between sexes. Age and BMI were treated as continuous variables and compared between sexes using T test. All other variables were treated as categorical and compared using Fisher’s exact test

ISSN: 1472-6823